Oct 2026· Frontiers in Neuroscience· Vol 20· 0 citations· 67 references
Medicine
TL;DR
The findings suggest limited overlap in significant metabolite associations across both cognitive performance and neural network activity, which may reflect some degree of domain specificity.
Abstract
Background Alterations in systemic metabolism may reflect biological processes relevant to brain function and cognitive aging, yet the extent to which circulating metabolites relate to both cognitive performance and underlying neural network activity remains unclear. Methods The current study included 112 cognitively normal participants of the Reference Abilities Neural Network study at Columbia University who had metabolomic, cognitive, and imaging data available at baseline. Cognition was measured using a neuropsychological battery including three tests for each of the four cognitive domains of memory, reasoning, processing speed, and language. Participants underwent fMRI while performing 12 tasks, 3 per domain, to derive domain-specific neural network activation pattern scores such that patterns correlated positively with behavioral performance. Plasma collected from participants were analyzed using an untargeted liquid chromatography coupled high-resolution mass spectrometry-metabolomics assay to generate metabolic profiles. Linear regression was used to explore associations between metabolite features and outcomes including cognition and neural network activation pattern scores. Results Participants had a mean age of 56.6 years (standard deviation (SD) = 15.6), 50.0% were female, 71.4% were white, and the mean education level was 15.8 years (SD = 2.2). Of the 4,286 metabolite features analyzed, 8 were significantly associated with neural network activation pattern scores for reasoning, but no other domains after false discovery rate (FDR) adjustment. In contrast, no metabolite features were significantly associated with any cognitive domains of memory, reasoning, processing speed or language after FDR adjustment. Exploratory analyses using nominal p-values revealed minimal overlap in metabolite features associated with domain-specific cognitive performance and neural network measures. Six metabolite features were associated with all neural network domains, whereas only one metabolite feature was associated with all cognitive domains. Pathway-level analyses did not demonstrate consistent enrichment across domains, but suggested involvement of amino acid metabolism, lipid metabolism, energy production, cofactor and vitamin metabolism, and nitrogen handling pathways. Conclusion Our findings suggest limited overlap in significant metabolite associations across both cognitive performance and neural network activity, which may reflect some degree of domain specificity. Neural network measures may capture aspects of underlying biological processes that are not fully reflected in cognitive test performance.
With an ageing population, the social and economic burden of cognitive decline is increasing. Urinary metabolomics may offer a promising approach for identifying metabolic markers for early cognitive impairment and gaining insights into underlying biological mechanisms. The aim of this study was to investigate the asso...
A. Kneipp, Inge Kirchberger, D. Freuer et al.· Metabolic brain disease· 1 citation
This study identified several urinary metabolites which were differentially linked to cognitive performance in T2D, and Sucrose, trans-aconitate, 4-hydroxyhippurate, and 4-deoxythreonate were associated with delayed memory.
Serena Low, Hui-Li Zheng, A. Moh et al.· Journal of Alzheimer's Disea...· 0 citations
Network-specific associations between cardiometabolic risk and DMN organization are suggested to be detectable in indi viduals with MCI, a clinical state preceding dementia, as well as in some degree within cognitively unimpaired individuals.
Zachary D. Green, S. O'Bryant, Leigh A. Johnson et al.· Frontiers in Neuroscience· 0 citations
Background The MIND diet supports healthy cognitive aging. Yet, a challenge remains to identify individuals who do not adhere to the MIND and could be at risk for accelerated cognitive decline. A multi-metabolite biomarker panel could facilitate population screening. Objectives To determine and validate a blood metabol...
Jeanne Neuffer, R. González-Domínguez, S. Lefèvre-Arbogast et al.· The journal of prevention of...· 0 citations
ABSTRACT Background Blood‐based biomarkers are increasingly used to identify Alzheimer's disease (AD) pathology and may play an important role in early disease screening and participant selection for clinical trials. However, their performance across stages of cognitive impairment remains unclear. This study examined w...
Maryam Abdolmaleki, Leslie S. Gaynor, Dan-Dan Liu et al.· Annals of Clinical and Trans...· 2 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.